1780P Clinical utility of the ESMO Precision Medicine Working Group recommendation on indication for germline follow-up testing in tumour-only sequencing

T Kondo,M Kanai,Y Yamamoto,K Fukuyama,J Matsubara,Q Pham Nguyen,M Yoshioka,T Yamada,S Kosugi,M Muto

doi:10.1016/j.annonc.2021.08.1723

1780P Clinical utility of the ESMO Precision Medicine Working Group recommendation on indication for germline follow-up testing in tumour-only sequencing

T Kondo, M Kanai + Show 8 more

Open Access

https://doi.org/10.1016/j.annonc.2021.08.1723

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2021
License type: publisher-specific-oa

Affiliation: Kyoto University

#Daily Clinical Practice #Daily Practice + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

European Society for Medical Oncology Precision Medicine Working Group (ESMO-PMWG) published the recommendations regarding germline follow-up testing of tumour-only sequencing based on tumour-normal sequencing data (Mandelker D. Ann Oncol 2019). Clinical studies examining whether this criterion can be applied in daily clinical practice are limited.

Full Text